Per the seekingalpha piece: "So, in terms of the guidance for the full year on a non-GAAP basis, we are expecting a loss in the $45 million to $50 million range, which translates to $0.85 to $0.95 per share on 53.3 million weighted shares outstanding." That works out to roughly .80/share cash at June 30th.
So, I guess you can read and dig and use the figures that make you happy....
Yahoo also shows them with 8.24 million debt.
Either way, imo, that is lots of cash vs. the share price I have been buying them at the last couple days, (.28-.29).
http://finance.yahoo.com/q/ks?s=NRGN
http://seekingalpha.com/article/93510-neurogen-corporation-q2-2008-earnings-call-transcript?source=yahoo&page=6
Take Care.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM